calendar
5,335 catalysts · 4,779 phase readout · 2,339 8k filing · 285 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion
next 91 dayslessmore
MonWedFri
5,335 catalysts · 4,779 phase readout · 2,339 8k filing · 285 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion
Sponsor: Assiut University. Phase: . Conditions: Multiple Sclerosis
Sponsor: Region Skane. Phase: . Conditions: Lynch Syndrome
Sponsor: Xijing Hospital. Phase: PHASE4. Conditions: Rebleeding of Portal Hypertension in Liver Cirrhosis, Propranolol, Carvedilol
Sponsor: University of Liverpool. Phase: PHASE1. Conditions: Osteoarthritis
Sponsor: University of Sharjah. Phase: NA. Conditions: Crowding of Anterior Mandibular Teeth
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Minor Patient Treated by One or More Antiretroviral and for Which a Blood Test Has Been Performed
Sponsor: University of Washington. Phase: . Conditions: Prostatic Neoplasms
Sponsor: Liu Tian. Phase: . Conditions: Takayasu Arteritis
Sponsor: The Royal Ottawa Mental Health Centre. Phase: NA. Conditions: Schizophrenia
Sponsor: Columbia University. Phase: NA. Conditions: Atrial Fibrillation, Patient Engagement
Sponsor: Nantes University Hospital. Phase: NA. Conditions: Congenital Heart Defects, Neurodevelopmental Disorder
Sponsor: Fulgent Pharma LLC.. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma
Sponsor: Hoffmann-La Roche. Phase: . Conditions: Traumatic Brain Injury
Sponsor: University of California, San Francisco. Phase: NA. Conditions: Food Insecurity, Kidney Transplant
Sponsor: National Cancer Institute (NCI). Phase: NA. Conditions: Neurofibromatosis 1, Noonan Syndrome, Legius Syndrome, Cardiofaciocutaneous Syndrome, Costello Syndrome
Sponsor: Comanche Biopharma. Phase: PHASE1. Conditions: sFlt1 Mediated Preterm Preeclampsia, Preeclampsia, Preterm Preeclampsia
Sponsor: Centre Hospitalier Régional d'Orléans. Phase: . Conditions: Pseudomonas Infections, Pseudomonas Aeruginosa, Prognosis, Drug Resistance, Multiple, Bacterial, Antibacterial Agents, Beta-lactam Antibiotics
Sponsor: Sun Pharmaceutical Industries Limited. Phase: PHASE3. Conditions: Active Psoriatic Arthritis
Sponsor: SIFI SpA. Phase: . Conditions: Acanthamoeba Keratitis
Sponsor: University of Southern California. Phase: . Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Invasive Breast Carcinoma
Sponsor: Marmara University. Phase: NA. Conditions: Healthy Participants
Sponsor: Ain Shams University. Phase: NA. Conditions: Regenerative Endodontic Treatment, Cleaning and Shaping Only With Proper Coronal Seal, Necrotic Mature First Premolar
Sponsor: Medical University of Warsaw. Phase: NA. Conditions: Dental Anxiety, Music Therapy, Oral Surgical Procedures
Sponsor: Military University Hospital, Prague. Phase: NA. Conditions: Cirrhosis, Portal Hypertension, EUS, Non-Cirrhotic Portal Hypertension, HVPG, Hepatic Venous Pressure Gradient
Sponsor: General Hospital of Shenyang Military Region. Phase: . Conditions: Ischemic Stroke
Sponsor: Vanda Pharmaceuticals. Phase: PHASE3. Conditions: Generalized Pustular Psoriasis
Sponsor: Trisha Wise-Draper. Phase: PHASE2. Conditions: Head and Neck Cancer
Sponsor: Tarik Emre Sener. Phase: NA. Conditions: Pediatric Urology
Sponsor: Spital Thurgau AG. Phase: NA. Conditions: Physical Deconditioning
Sponsor: University of Michigan. Phase: . Conditions: Hepatic Encephalopathy
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Neoplasm, Stage IV Colorectal Cancer AJCC v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7, Unresectable Solid Neoplasm
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal Carcinoma, Recurrent Fallopian Tube Clear Cell Adenocarcinoma, Recurrent Fallopian Tube Endometrioid Adenocarcinoma, Recurrent Fallopian Tube High Grade Serous Adenocarcinoma, Recurrent Fallopian Tube Mucinous Adenocarcinoma, Recurrent Fallopian Tube Transitional Cell Carcinoma, Recurrent Fallopian Tube Undifferentiated Carcinoma, Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma, Recurrent Ovarian Endometrioid Adenocarcinoma, Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Ovarian Low Grade Serous Adenocarcinoma, Recurrent Ovarian Mucinous Adenocarcinoma, Recurrent Ovarian Seromucinous Carcinoma, Recurrent Ovarian Transitional Cell Carcinoma, Recurrent Ovarian Undifferentiated Carcinoma, Recurrent Platinum-Resistant Fallopian Tube Carcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma, Recurrent Platinum-Resistant Primary Peritoneal Carcinoma, Recurrent Primary Peritoneal Clear Cell Adenocarcinoma, Recurrent Primary Peritoneal Endometrioid Adenocarcinoma, Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma, Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma, Recurrent Primary Peritoneal Transitional Cell Carcinoma, Recurrent Primary Peritoneal Undifferentiated Carcinoma, Refractory Fallopian Tube Clear Cell Adenocarcinoma, Refractory Fallopian Tube Endometrioid Adenocarcinoma, Refractory Fallopian Tube High Grade Serous Adenocarcinoma, Refractory Fallopian Tube Mucinous Adenocarcinoma, Refractory Fallopian Tube Transitional Cell Carcinoma, Refractory Fallopian Tube Undifferentiated Carcinoma, Refractory Low Grade Fallopian Tube Serous Adenocarcinoma, Refractory Ovarian Clear Cell Adenocarcinoma, Refractory Ovarian Endometrioid Adenocarcinoma, Refractory Ovarian High Grade Serous Adenocarcinoma, Refractory Ovarian Low Grade Serous Adenocarcinoma, Refractory Ovarian Mucinous Adenocarcinoma, Refractory Ovarian Seromucinous Carcinoma, Refractory Ovarian Transitional Cell Carcinoma, Refractory Ovarian Undifferentiated Carcinoma, Refractory Primary Peritoneal Clear Cell Adenocarcinoma, Refractory Primary Peritoneal Endometrioid Adenocarcinoma, Refractory Primary Peritoneal High Grade Serous Adenocarcinoma, Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma, Refractory Primary Peritoneal Transitional Cell Carcinoma, Refractory Primary Peritoneal Undifferentiated Carcinoma
Sponsor: CHU de Reims. Phase: . Conditions: Intensive Care, Pupil Assessment, Pupillometry, Neurological Examination, Clinical Competence, Nursing Assessment, Diagnostic Techniques and Procedures, Comparative Effectiveness Research, Interprofessional Relations, Observer Variation
Sponsor: Milton S. Hershey Medical Center. Phase: NA. Conditions: Eating Disorders, Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder
Sponsor: Bionoxx Inc.. Phase: PHASE1. Conditions: Treatment-Refractory Solid Tumors
Sponsor: National Taiwan University Hospital. Phase: PHASE1. Conditions: Metastatic Castration Resistant Prostate Cancer (mCRPC)
Sponsor: University of Glasgow. Phase: NA. Conditions: Healthy
Sponsor: The Cleveland Clinic. Phase: NA. Conditions: Spontaneous Labor
Sponsor: Institut de Recherches Cliniques de Montreal. Phase: . Conditions: Type1diabetes
Sponsor: Johns Hopkins University. Phase: NA. Conditions: Olfactory Dysfunction, Smell Loss, Anosmia, Hyposmia
Sponsor: USMARI Research & Innovation Centre. Phase: NA. Conditions: Healthy
Sponsor: Muazez küçükkaya. Phase: NA. Conditions: Cervical Cancers
Sponsor: Istituti Clinici Scientifici Maugeri SpA. Phase: . Conditions: Cardiovascular Disease
Sponsor: Novartis Pharmaceuticals. Phase: PHASE3. Conditions: Atherosclerotic Cardiovascular Disease (ASCVD)
Sponsor: University of Wisconsin, Madison. Phase: . Conditions: Skin Cancer, Melanoma (Skin Cancer), Basal Cell Carcinoma of Skin, Basal Cell Carcinoma of Skin, Site Unspecified, Cutaneous Squamous Cell Carcinoma (CSCC), Merkel Cell Carcinoma of Skin
Sponsor: The University of Hong Kong. Phase: EARLY_PHASE1. Conditions: Infection-Associated Acute Kidney Injury
Sponsor: University of Chicago. Phase: PHASE2. Conditions: Sickle Cell Disease, Acute Chest Syndrome
Sponsor: Islamabad Medical and Dental College. Phase: NA. Conditions: Colorectal Cancer
Sponsor: Gilead Sciences. Phase: PHASE3. Conditions: Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Sponsor: Averitas Pharma, Inc.. Phase: PHASE3. Conditions: Post Surgical Neuropathic Pain